Full-cost determination of different levels of care in the intensive care unit - An activity-based costing approach

被引:9
作者
Doyle, JJ [1 ]
Casciano, JP [1 ]
Arikian, SR [1 ]
Mauskopf, J [1 ]
Paul, JE [1 ]
机构
[1] CTR HLTH OUTCOMES & ECON, E BRUNSWICK, NJ USA
关键词
D O I
10.2165/00019053-199610040-00008
中图分类号
F [经济];
学科分类号
02 [经济学];
摘要
We applied an activity-based costing methodology to determine the full cost of intensive care service at a community hospital, a university hospital and a health maintenance organisation (HMO)-affiliated hospital. A total of 5 patient care units were analysed: the intensive care unit (ICU) and surgical ICU (SICU) at the university setting, the ICU at the community setting, and the SICU and cardiac care unit at the HMO setting. The selection of the different ICU types was based on the types of critical care units that were found in each setting (e.g. the HMO did not have an ICU). institution-specific cost data and clinical management parameters were collected through surveys and site visits from the 3 respective organisation types. The analysis revealed a marked increase in patient-minute cost associated with mechanical ventilation. Higher costs associated with prolonged neuromuscular blockade have important economic implications with respect to selection of an appropriate neuromuscular blocking agent.
引用
收藏
页码:395 / 408
页数:14
相关论文
共 30 条
[1]
CLINICAL PHARMACOKINETICS OF NEUROMUSCULAR BLOCKING-DRUGS [J].
AGOSTON, S ;
VANDENBROM, RHG ;
WIERDA, JMKH .
CLINICAL PHARMACOKINETICS, 1992, 22 (02) :94-115
[2]
ARIKIAN SR, 1992, MED MARKETING ME NOV, P60
[3]
BERMAN H, 1994, FINANC MANAGE, P175
[4]
PROLONGED NEUROMUSCULAR BLOCKADE WITH ATRACURIUM [J].
BIZZARRISCHMID, MD ;
DESAI, SP .
CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1986, 33 (02) :209-212
[5]
BOOTMAN JL, 1991, PRINCIPLES PHARMACOE, P3
[6]
*CAN COORD OFF HLT, 1994, GUID EC EV PHARM, P17
[7]
NEUROMUSCULAR COMPLICATIONS IN PATIENTS GIVEN PAVULON (PANCURONIUM-BROMIDE) DURING ARTIFICIAL-VENTILATION [J].
DECOUL, AAWO ;
LAMBREGTS, PCLA ;
KOEMAN, J ;
VANPUYENBROEK, MJE ;
TERLAAK, HJ ;
GABREELSFESTEN, AAWM .
CLINICAL NEUROLOGY AND NEUROSURGERY, 1985, 87 (01) :17-22
[8]
ELLENDER PJ, 1994, HOSP PHARM, V29, P36
[9]
Evans D B, 1992, Pharmacoeconomics, V1, P5, DOI 10.2165/00019053-199201010-00003
[10]
DOXACURIUM - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL POTENTIAL IN ANESTHESIA [J].
FAULDS, D ;
CLISSOLD, SP .
DRUGS, 1991, 42 (04) :673-689